Regulation & law · 18/11/1996
FDA Clarifies Environmental Information Requirements for Paclitaxel Drug Products
The FDA is issuing a document to outline the environmental information needed for drug products containing paclitaxel, a key ingredient in various cancer treatments, to ensure that environmental factors are adequately assessed under the National Environmental Policy Act.
Original source language: Federal Register — All DocumentsOpen original release →